TriangleHEALTH PROFESSIONAL · SOURCE READING
Resection of oligometastatic disease
Source: Renal Cell Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 13, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Stage IV and Recurrent Renal Cell Cancer / Local Therapy / Cytoreductive nephrectomy
Selected patients with solitary or a limited number of distant metastases can achieve prolonged survival with nephrectomy and surgical resection of the metastases.[48-53] Even patients with brain metastases had similar results.[54] The likelihood of achieving therapeutic benefit with this approach appears enhanced in patients with a long disease-free interval between the initial nephrectomy and the development of metastatic disease.
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice